MIM Fertility
MIM Fertility is a deeptech company specializing in AI-powered solutions for In Vitro Fertilization (IVF). Their mission is to make AI the standard of care in reproductive medicine by providing cutting-edge tools that enhance diagnosis and treatment, increase success rates, and reduce the time and cost of fertility procedures. The company was founded by Piotr Wygocki (CTO) and Ula Sankowska (CEO), inspired by personal experiences with fertility challenges. They leverage their deep pedigree in algorithm development and academic research to solve complex problems in reproductive medicine. MIM Fertility's core values include innovation with purpose, scientific integrity, patient empathy, precision, empowering professionals, and scalable impact. Their products, such as FOLLISCAN, EMBRYOAID, and ENDOSCAN, are designed to support IVF doctors, clinicians, embryologists, and patients, acting as co-pilots to enhance decision-making and improve patient outcomes. The company has received several awards for scientific excellence, entrepreneurship, and innovation, and its founders have individual achievements recognized in AI and business.
MIM Fertility
MIM Fertility is a deeptech company specializing in AI-powered solutions for In Vitro Fertilization (IVF). Their mission is to make AI the standard of care in reproductive medicine by providing cutting-edge tools that enhance diagnosis and treatment, increase success rates, and reduce the time and cost of fertility procedures. The company was founded by Piotr Wygocki (CTO) and Ula Sankowska (CEO), inspired by personal experiences with fertility challenges. They leverage their deep pedigree in algorithm development and academic research to solve complex problems in reproductive medicine. MIM Fertility's core values include innovation with purpose, scientific integrity, patient empathy, precision, empowering professionals, and scalable impact. Their products, such as FOLLISCAN, EMBRYOAID, and ENDOSCAN, are designed to support IVF doctors, clinicians, embryologists, and patients, acting as co-pilots to enhance decision-making and improve patient outcomes. The company has received several awards for scientific excellence, entrepreneurship, and innovation, and its founders have individual achievements recognized in AI and business.
TL;DR
Headquarters: Warsaw, Poland
Founded: 2019
Focus: AI/ML products for IVF (FOLLISCAN, EMBRYOAID, ENDOSCAN)
Recent funding: Seed - USD 2,000,000 (Dec 4, 2023)
Employees: ~25
Company Overview
Problem Domain
Reproductive medicine / in vitro fertilization (IVF) clinical decision support
Founded
2019
Industry
Medtech / Digital health
Funding Track Record
2000000.00
Investors named: Tangent Line Ventures and Peleton
Investor Signal
“Tangent Line Ventures; Peleton”